The COVID-19 pandemic has highlighted the public need for molecular diagnostic tools to identify pathogen panels through nucleic acid amplification tests (NAAT). Many clinical labs worldwide have now established infrastructures for routine molecular assays using classic quantitative PCR (qPCR). In order to further advance this – now routine – tool for in vitro diagnostics (IVD), […]
Read More